Brief: Cannasouth Says Three Cannabinoid Products Successfully Assessed By Medicinal Cannabis Agency
19/05/2022 02:32
May 19 (Reuters) - Cannasouth Ltd CBD.NZ :
* THREE CANNABINOID PRODUCTS SUCCESSFULLY ASSESSED BY
MEDICINAL
CANNABIS AGENCY
Source text for Eikon: ID:
Further company coverage: CBD.NZ
Recent news on Cannasouth
See all newsBrief: Cannasouth Confirms That NZ Regco Accepted Application To Delist From NZX
Brief: Cannasouth Launches Wholesale Offer Of Secured Convertible Notes To Raise Up To NZ$2.4 Mln
Brief: Cannasouth Says Resignation Of CEO, Mark Lucas, Effective 8 April
Brief: Cannasouth Says Colin Foster Resigns As CFO
Brief: NZ Regco Says Cannasouth Requested Further Trading Halt On Ordinary Shares